Which Walking Tests Are Most Responsive to Improvement in Patients With MS?November 5, 2013Multiple Sclerosis
COMMENTARY—The Principal Site of MS-Related Tissue Injury Remains UnclearNovember 5, 2013Multiple Sclerosis
2010 McDonald Criteria Are Effective for Early Diagnosis of Pediatric MSNovember 1, 2013Multiple Sclerosis
Pre- and Post-Progression Relapses Impact Disability in Progressive MSOctober 7, 2013Multiple Sclerosis
Anti-Lipid Oligoclonal IgM Bands Contribute to PML Risk StratificationOctober 7, 2013Multiple Sclerosis
Comparing Relapse Rates Among Patients With MS Who Switch From Interferon to Fingolimod or Glatiramer AcetateOctober 4, 2013Multiple Sclerosis
Regulation May Be Impaired in Patients With Secondary Progressive MSSeptember 30, 2013Multiple Sclerosis
Brain Atrophy and Lesion Load Predict Long-Term Disability in Multiple SclerosisSeptember 30, 2013Multiple Sclerosis
FDA Investigates Case of PML in Patient With MS Taking FingolimodSeptember 30, 2013Multiple Sclerosis
